CoChat

Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida

Open access
Lungarotti, M S, Mezzetti, D, Radicioni, M · 2003 · Archives of Disease in Childhood - Fetal and Neonatal Edition
Cited by 20

The DOI matches its Crossref record.

Abstract

Late anaemia in Rh haemolytic diseaseAs it is clearly stated in the review by Gottstein and Cooke, 1 we consider it unethical to withhold or delay high dose intravenous immunglobulin (IVIG) treatment in infants with haemolytic disease of the newborn.Since the study we did in 1995, 2 we have treated 129 patients with Coomb's positive haemolytic disease of the newborn, with the same method and had to resort to exchange transfusions only in three cases.On the other hand, late anaemia is a frequent problem in these cases, necessitating multiple blood transfusions, with well known complications.The authors suggest that multiple doses of IVIG may reduce late anaemia.However, our observation in a limited number of cases is that, even multiple doses of IVIG are ineffective in preventing late anaemia.In an earlier unpublished study, we had shown that the erythropoietin levels were low in these infants.Therefore, we had conducted a double blind, randomised pilot study to investigate the effects of recombinant erythropoietin (rHEPO) in these patients.3 In this study, rHEPO was administered at a dose of 200 units/kg, subcutaneously, three times a week, starting at the 14th day of life and lasting for six weeks.This protocol reduced the number of erythrocyte transfusions significantly.With the impetus of this pilot study, we have used the same protocol for the subsequent 103 patients and the mean number of transfusions in this group was 1.5, with the majority of patients (55%) not needing any transfusions at all.There were no complications, including changes in neutrophil or platelet counts, and haemorrhagic or infectious complications.The administration of rHEPO to patients with haemolytic disease of the newborn, who had received IVIG early in life, not only decreases the infants' exposure to multiple blood donors, but also diminishes the need for hospitalisation and hence the cost that is involved.Therefore, rHEPO treatment is a suitable alternative to erythrocyte transfusions in these infants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/fn.88.5.f446

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 20

Metadata

Authors
Lungarotti, M. S., Mezzetti, D., & Radicioni, M.
Venue
Archives of Disease in Childhood - Fetal and Neonatal Edition
Publisher
BMJ
Published
2003-09
Volume
88
Issue
5
Pages
F446.1-F446
ISSN
  • 1359-2998 (ISSN-L)
  • 1468-2052
OpenAlex
W2167071355
Cited by
20
References
0
FWCI
0.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida. https://app.cochat.ai/papers/10.1136/fn.88.5.f446
The paper
Lungarotti, M. S., Mezzetti, D., & Radicioni, M. (2003). Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida. Archives of Disease in Childhood - Fetal and Neonatal Edition. https://doi.org/10.1136/fn.88.5.f446

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.